 Home > Active Ingredient News > Study of Nervous System > Stroke: Outcome of endovascular treatment in patients with mobility impairment before stroke

Stroke: Outcome of endovascular treatment in patients with mobility impairment before stroke

 Last Update: 2021-09-19
 Source: Internet
 Author: User

Tags

6 32 pill

prolene 3 0

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Patients with pre- stroke mobility impairment (PSMI) were excluded from intravascular clinical trials
.

There are very limited data on the safety and outcome of intravascular thrombectomy in this population

Stroke blood clot

Recently, a research article was published in Stroke, an authoritative journal in the field of cardiovascular disease.
Researchers used a large national data set to evaluate the safety and outcome of intravascular thrombectomy in patients with PSMI
.

Cardiovascular

The researchers included patients who underwent endovascular thrombectomy between 2015 and 2019
.

PSMI is defined as the inability to walk independently

Although the incidence of adverse surgical outcomes in PSMI patients has not increased, further research is needed to determine the clinical benefit of this population

Original source:

Rachel Beekman.

et al.
Outcomes of Endovascular Therapy in Patients With Prestroke Mobility Impairment .
stroke.
2021.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Pregabalin Crystal CAS 148553-50-8 Lyrica Powder 99.0% White Powder Mobelbiochem

CAS No.: 148553-50-8

Pharmacy Grade

$35.00/KG FOB

High purity Zonisamide 98% with best price 68291-97-4 and Zonisamide raw material

CAS No.: 68291-97-4

Pharmacy Grade

$8.8-10/MT FOB

Choline chloride 99% powder

CAS No.: 67-48-1

Pharmacy Grade

$8-10/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.